SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
Healthcare
$29.68 +2.49%
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
52W Low $17.06High $32.44
Volume 0.10M
Average 0.09M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$41.45M
FY 2025 · Annual
Net Income
-$39.87M
FY 2025 · Annual
Income Statement
USD
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 0 |
| Cost of Revenue | 612K |
| Gross Profit | (612K) |
| Gross Margin | — |
| Research & Development | 28.64M |
| Selling, General & Admin | 12.2M |
| Operating Expenses | 40.84M |
| Depreciation & Amortization | 612K |
| EBITDA | (39.26M) |
| EBITDA Margin | — |
| Operating Income | (41.45M) |
| Operating Margin | — |
| Interest Income | 3.11M |
| Interest Expense | 0 |
| Other Income / Expenses | 1.58M |
| Income Before Tax | (39.87M) |
| Pre-Tax Margin | — |
| Income Tax Expense | 0 |
| Net Income | (39.87M) |
| Net Margin | — |
| EPS (Basic) | (1.19) |
| EPS (Diluted) | (1.19) |
| 33.43M | |
| 33.43M |
SGP Earnings Waterfall · TTM
NASDAQ:SGP · Revenue to Net Income
No earnings data available.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Oct 19, 2026 | |
| 8-K | Current report | Oct 1, 2026 | |
| 10-Q | Quarterly report | Aug 6, 2026 |
How much revenue does SGP generate?
SpyGlass Pharma, Inc. Common Stock (SGP) reported $0.00 of revenue in fiscal 2025.
Is SGP profitable?
SpyGlass Pharma, Inc. Common Stock (SGP) reported -$39.87M of net income.
Continue the stock analysis
Jump to another research area for this company.